Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 79.65% is in line with its 5-year average of 75.68%, near the high end of its 5-year range (-3319.53%–104.19%).
113.22% above its 12-month average of -602.54%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 73.16%.
GROSS MARGIN
79.65%
GROSS MARGIN AVG TTM
-602.54%
GROSS MARGIN AVG 3Y
75.33%
GROSS MARGIN AVG 5Y
75.68%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+113.22%
CURRENT VS 3Y AVG
+5.73%
CURRENT VS 5Y AVG
+5.25%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.82%
median of 729 covered companies
CURRENT VS SECTOR MEDIAN
+95.12%
vs the sector median at left
Nexalin Technology, Inc.
Market Cap
$3.58M
Gross Margin
79.65%
TTM Avg
-602.54%
3Y Avg
75.33%
5Y Avg
75.68%
Market Cap
$3.59M
Gross Margin
0.00%
TTM Avg
41.76%
3Y Avg
-40.89%
5Y Avg
-27.26%
Market Cap
$3.27M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
50.00%
Market Cap
$3.26M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.26M
Gross Margin
16.54%
TTM Avg
-251.00%
3Y Avg
-125.05%
5Y Avg
-78.44%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | $3.58M | 79.65% | -602.54% | 75.33% | 75.68% |
| Evogene Ltd. (EVGN)vs › | $3.55M | -6.25% | 25.54% | 36.71% | 34.86% |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| Eocene Ltd. (EOCN)vs › | $3.48M | N/A | N/A | N/A | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.59M | 0.00% | 41.76% | -40.89% | -27.26% |
| Moolec Science S.A. (MLEC)vs › | $3.39M | 34.17% | 21.29% | 6.69% | 5.35% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.27M | 0.00% | 0.00% | 25.00% | 50.00% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.26M | 0.00% | 0.00% | 0.00% | 0.00% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.26M | 16.54% | -251.00% | -125.05% | -78.44% |
| MBody AI Ltd. (MBAI)vs › | $3.16M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
79.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 73.16% |
| 2026-03-31 | -3319.53% |
| 2025-12-31 | 87.77% |
| 2025-09-30 | 78.25% |
| 2025-06-30 | 67.65% |
| 2025-03-31 | 66.94% |
| 2024-12-31 | 72.42% |
| 2024-09-30 | 64.77% |
| 2024-06-30 | 73.00% |
| 2024-03-31 | 88.36% |
| 2023-12-31 | 74.53% |
| 2023-09-30 | 83.52% |
| 2023-06-30 | 73.62% |
| 2023-03-31 | 76.73% |
| 2022-12-31 | 82.13% |
| 2022-09-30 | 65.65% |
| 2022-06-30 | 70.30% |
| 2022-03-31 | 85.77% |
| 2021-12-31 | 104.19% |
| 2021-09-30 | 83.37% |
| 2021-06-30 | 69.96% |
| 2021-03-31 | 87.46% |
| 2020-12-31 | 59.58% |
| 2020-09-30 | 86.04% |
| 2020-06-30 | 93.81% |
| 2020-03-31 | 93.81% |
